Skip to main content
    S

    Sionna Therapeutics, Inc. Common Stock (SION)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.28
    +0.00 (+0.00%)

    Market Cap: $148.30M

    Last updated: Nov 06, 2026 at 4:34 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    50%(4/8)
    Avg Surprise
    -0.70%
    Streak
    1 Q

    Upcoming Estimates

    Period ending Dec 31, 2026
    EPS Consensus$-0.62
    Range$-0.82 - $-0.11
    10 analysts
    Revenue Consensus
    $0
    Range$0 - $0
    10 analysts
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Dec 26EST
    		-$-0.62$-0.82 - $-0.11--10--
    Sep 26
    Reported Nov 4
    		$-0.46$-0.62$-0.84 - $-0.53+25.81%Beat8
    2
    1
    30d
    		+0.0%
    Jun 26
    Reported Aug 6
    		$-0.66$-0.64$-0.69 - $-0.61-3.13%Miss9
    0
    6
    30d
    		-61.0%
    Mar 26
    Reported May 12
    		$-0.60$-0.50$-0.57 - $-0.47-20.00%Miss8
    1
    2
    30d
    		+3.2%
    Dec 25
    Reported Mar 2
    		$-0.46$-0.71$-0.71 - $-0.47+35.21%Beat8
    0
    2
    30d
    		+86.4%
    Sep 25
    Reported Nov 5
    		$-0.46$-0.52$-0.54 - $-0.50+11.54%Beat2
    1
    1
    30d
    		-
    Jun 25
    Reported Aug 11
    		$-0.41$-0.45$-0.49 - $-0.44+8.89%Beat2
    1
    1
    30d
    		-
    Mar 25
    Reported May 12
    		$-0.62$-0.45--37.78%Miss---
    Dec 24
    Reported Mar 20
    		$-3.38$-2.68--26.12%Miss---

    Key Metrics

    Valuation
    P/E Ratio-1.50EV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE-32.30%ROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio20.05xQuick Ratio20.05x
    Trading Statistics
    BetaN/AAvg Volume959.14K
    52-Week High$54.9752-Week Low$3.25

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$3.71
    SMA 20$3.88
    SMA 50$5.21
    SMA 200$29.19
    EMA 10$3.66
    EMA 20$4.04
    EMA 50$7.68
    EMA 200$22.59

    MACD

    Line: -0.73Signal: -0.88Hist: 0.15

    ADX

    ADX: 43.0+DI: 12.7-DI: 36.3

    Aroon & PSAR

    Aroon UpN/A
    Aroon Down100.0
    PSAR$7.97

    Bollinger Bands

    Upper Band$4.54
    Lower Band$3.23
    %B Position3389%(Upper)
    Band Width0.04

    RSI (14-Day)

    Oversold
    26.5

    Momentum Oscillators

    Stoch %K12.5
    Stoch %D15.7
    Williams %R-92.0
    ROC (10d)-8.9%
    Momentum-0.32
    CCI (20d)-171.1
    MFI (14d)39.1

    Volatility Measures

    ATR (14d)$0.39(12.0%)
    StdDev (20d)0.33
    Hist Vol71.3%(High)

    Volume Flow

    VWAP$3.28
    OBV4.7M
    AD Line8.9M
    CMF (20d)-0.249

    Volume Metrics

    Avg Vol (20d)977.6K
    Vol Ratio1.0x
    VWMA (20d)$3.88

    Pivot Points

    R3$4.04
    R2$3.87
    R1$3.58
    Pivot Point$3.41
    S1$3.12
    S2$2.95
    S3$2.66

    Advanced Oscillators

    TSI-43.55
    Ultimate Osc34.7
    KST-292.14

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total Revenue$0$0$0$0$0$0$0$0$0$0$0
    Cost of Revenue$0$0$152,000$0$0$0N/A$0$0$0N/A
    Gross Profit$0$0$-152,000$0$0$0N/A$0$0$0N/A
    Operating Expenses$32.47M$29.60M$23.61M$23.80M$21.73M$19.66M$18.13M$27.98M$11.29M$13.15M$12.60M
    R&D$21.86M$18.96M$15.17M$16.04M$15.38M$13.67M$14.25M$24.58M$8.23M$10.22M$9.89M
    SG&A$10.61M$10.64M$8.44M$7.76M$6.52M$5.99M$3.88M$3.40M$3.06M$2.93M$2.71M
    Operating Income$-32,470,000$-29,599,000$-23,612,000$-23,805,000$-21,906,000$-19,659,000$-18,133,000$-27,984,000$-11,292,000$-13,147,000$-12,595,000
    Interest Income$2.59M$2.82M$3.17M$3.46M$3.67M$3.00M$2.12M$2.35M$2.57M$1.13M$553,000
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$-29,883,000$-26,779,000$-20,859,000$-20,278,000$-18,239,000$-16,482,000$-15,848,000$-25,441,000$-8,552,000$-11,847,000$-11,876,000
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-29,886,000$-26,779,000$-20,440,000$-20,278,000$-18,068,000$-16,482,000$-15,848,000$-25,441,000$-8,552,000$-11,847,000$-11,876,000
    EBITDA$-32,472,000$-29,645,000$-23,813,000$-24,381,000$-23,416,000$-19,529,000$-18,590,000$-28,622,000$-12,055,000$-12,924,000$-11,715,000
    EBIT$-32,470,000$-29,599,000$-23,612,000$-23,734,000$-21,906,000$-19,482,000$-17,967,000$-27,794,000$-11,118,000$-12,979,000$-11,876,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about SION

    News

    Form 4 Sionna Therapeutics Inc: Charlotte McKee (CMO and Head of R&D) For: 17 September

    This article reports on a Form 4 filing for Sionna Therapeutics Inc, specifically detailing an insider transaction involving Charlotte McKee...

    Investing.com UK•11/2/26•Neutral

    Sionna Therapeutics to Participate in Upcoming November 2026 Investor Conferences

    Sionna Therapeutics, a clinical-stage biopharmaceutical company focused on cystic fibrosis, announced its participation in two investor conferences in November 2026. Management will hold fireside chats at Guggenheim's...

    The Manila Times•11/2/26•Neutral

    Sionna Therapeutics, Inc. (SION) Seasonal returns chart

    The article provides a seasonal returns chart for Sionna Therapeutics, Inc. (SION), displaying average monthly price returns for the periods of 2025-2026. It includes current stock information...

    Yahoo Finance Australia•10/31/26•Neutral

    Sionna Therapeutics, Inc. Estimates – NASDAQ:SION

    This page provides financial actuals and estimates for Sionna Therapeutics, Inc. (NASDAQ: SION). Users can explore reported financial data and analyst estimates across various financial statements and valuation metrics....

    TradingView•10/23/26•Neutral

    Sionna Therapeutics (SION) Options Chain & Prices 2026 $SION

    This article provides details on the options chain and prices for Sionna Therapeutics (SION) for 2026. It includes current stock prices, extended trading information...

    MarketBeat•10/20/26•Neutral

    SION Valuation and Fair Value

    P/E
    -1.5x
    P/B
    0.6x
    See GNG's fair value

    SION Profitability: Margins, ROIC and FCF

    Operating margin
    0.0%
    Net margin
    0.0%
    ROE
    -32.3%

    SION Competitors

    CompanyTicker
    Atrium Therapeutics, Inc. Common StockRNA
    MaxCyte IncMXCT
    Mersana Therapeutics IncMRSN
    MacroGenics IncMGNX
    Inovio Pharmaceuticals IncINO
    KORU Medical Systems, Inc.KRMD
    Sutro BiopharmaSTRO
    Solana CompanyHSDT

    Sector: Healthcare

    SION Analyst Ratings

    Consensus
    Hold
    Analysts
    12
    Strong Buy
    0
    Buy
    2
    Hold
    10
    Sell
    0
    Strong Sell
    0

    SION Earnings: Beat Rate and Next Report

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    -0.7%
    EPS estimate (fiscal period ending Dec 31, 2026)
    $-0.62

    SION Earnings Date

    SION reports Mar 1, 2027. The date is estimated.

    SION ETF Holders

    GNG tracks 9 ETFs that hold SION. The largest weights:

    1. abrdn Healthcare Investors (HQH), 1.40% of the fund
    2. Vanguard Russell 2000 Index Fund ETF Shares (VTWO), 0.02% of the fund
    3. iShares Biotechnology ETF (IBB), 0.01% of the fund
    4. iShares Russell 2000 ETF (IWM), 0.01% of the fund
    5. Vanguard Total Stock Market Index Fund Admiral Shares (VTSAX), <0.01% of the fund
    Open the ETF Stock Exposure tool for SION

    Frequently Asked Questions About SION

    When does SION report earnings?

    Sionna Therapeutics, Inc. Common Stock (SION) is expected to report earnings on Mar 1, 2027.

    Does SION pay dividends?

    Sionna Therapeutics, Inc. Common Stock (SION) does not currently pay a regular dividend.

    What is SION's market cap?

    Sionna Therapeutics, Inc. Common Stock (SION) has a market capitalization of $148.30M with a current stock price of $3.28.

    Related stocks

    Sector: Healthcare

    All stocks starting with S

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In